Partner Therapeuticsptxis A Biotechnology Company Based In The Boston Areaestablished In 2018The Company Focuses On Oncology And Serious Diseasesintegrating Researchmanufacturingdevelopmentand Commercialization To Provide Therapies That Enhance Health Outcomes And Lower Cancer Care Costsptx Collaborates With Cliniciansresearchersand Policymakers To Meet Unmet Medical Needsincluding Those Related To Infectious Diseases And Covid 19 Ptx Offers A Range Of Servicesincluding Drug Development For Late Stage Therapiesin House Manufacturing To Ensure Product Qualityand Patient Support Programs That Provide Financial Assistance And Educational Resourcesthe Companyae S Primary Product Is Leukinea Sargramostim An Fda Approved Immuno Stimulant Used For Treating Acute Myelogenous Leukemia And Managing Infections In Bone Marrow Transplant Recipientsptx Is Committed To Advancing Oncology Therapies With A Focus On Immune Modulation And Cost Effective Solutionswhile Maintaining A Patient Centric Approach To Therapy Design And Delivery
No conferences found for this company.
| Company Name | Partners Pharmaceuticals Inc |
| Country |
United States
|
| Address | 19 Muzzey Street Lexington Ma 02421 United States |
| Telephone | Login to View |
| Login to View |
